Valeant Pharmaceuticals (NYSE:VRX) announced that Spear Pharmaceuticals has agreed not to market, sell or ship a generic fluorouracil cream 5% pursuant to a stay in Valeant’s legal case against the Food and Drug Administration (FDA). The stay will remain in place until May 14, 2008, or until a further order of the Court is issued. On April 11, 2008, the FDA approved an Abbreviated New Drug Application (ANDA) for a fluorouracil cream 5% sponsored by Spear Pharmaceuticals.

This post is an original post by ScienceDaily: Skin Care News

Posted: May 7th, 2008 under skin health.
Comments: none

Researchers have discovered how a mole develops into melanoma by showing the interaction of two key proteins involved in 60-70 percent of tumors. The Penn State scientists also demonstrate that therapeutic targeting of these proteins is necessary for drugs to effectively treat this deadly form of cancer.

This post is an original post by ScienceDaily: Skin Care News

Posted: May 7th, 2008 under skin health.
Comments: none

At age 17, all Meghan Rothschild and Brittany Lietz wanted was a dark tan. They thought it made them look beautiful. But both had no idea that in just three years they would be battling melanoma, the deadliest form of skin cancer. Now Meghan, 24, of Wilbraham, Mass., and Brittany, 23, of Annapolis, Md., are speaking out about their experiences.

This post is an original post by ScienceDaily: Skin Care News

Posted: May 7th, 2008 under skin health.
Comments: none